New EU Medical Device Regulation | Updated Regulation 2018

Overview:

Regulation proposals of the European Commission Background

In 2012, the Commission adopted a package of measures on innovation in health. The package consisted of a Communication and two regulation proposals to revise existing legislation on general medical devices and in vitro diagnostic medical devices. In particular, the Directives on active implantable medical devices (90/385/EEC) and on medical devices (93/42/EEC) are intended to be replaced by a Regulation on medical devices, while the Directive on in-vitro diagnostic medical devices (98/79/EC) is intended to be replaced by a Regulation on the same subject. The revisions therefore affected all kinds of medical devices including in vitro diagnostic medical devices, from home-use items like sticking plasters, pregnancy tests and contact lenses, to X-ray machines, pacemakers, breast implants, hip replacements and HIV blood tests.

This Seminar will look at what to expect when the new regulation is implemented. Including: the transition period, Effect on Notified Bodies, Impact of the MDR on Quality Management Systems (QMS), technical documentation, clinical trial requirements, UDI and combination products.

Why you should attend:

Because the current Directive will be significantly altered and replaced by a Regulation which is legally binding on all Member States.

Areas Covered in the Session:

• The updated Regulation
• Implementation dates and transition
• Main changes and products affected
• Effect on medical device manufacturers

Who will benefit:

• Clinical Trial Managers
• Regulatory Affairs
• Medical Officers

Agenda:

Day 1 Schedule

Lecture 1 (90 Mins):

The new MDR main changes

• Main updates
• Transition periods
• Effect on medical device manufacturers
• Regulatory landscape

Lecture 2 (90 Mins):

Notified Bodies under the New MDR

• Effect on NBs
• When will NBs begin conformity assessment against the new Regulation?
• Main effect on medical device manufacturers

Lecture 3 (90 Mins):

Impact of the MDR on Quality Management Systems (QMS)

• When do I need to update my QMS?
• What main points need to be considered?
• Effect on medical device manufacturers

Lecture 4 (90 Mins):

Technical Documentation

• Class I and IIa devices
• Effect on class IIb devices
• Class III devices

CASE STUDY 1 - Including a walkthrough of expected outcomes for all case study exercises

Wrap up of day 1 & Q&A's

Day 2 Schedule

Lecture 1 (90 Mins):

Clinical aspects and testing

• Class I and IIa devices
• Effect on class IIb devices
• Class III devices

Lecture 2 (90 Mins):

Periodic Safety Update reports

• Content of PSUR
• Frequency

Lecture 3 (30 Mins):

Common Specification (CS)

Common Tech Specifications

Lecture 4 (90 Mins):

Combination Products

• Definitions
• Requirements
• Technical documentation

CASE STUDY 2 - Including a walkthrough of expected outcomes for all case study exercises

Wrap up of day 2 & Q&A's

Venue:  Hilton Zurich Airport Hohenbuhlstrasse 10, 8152 Opfikon-Glattbrugg, Switzerland

Price:

Price: $1,695.00 (Seminar Fee for One Delegate)

Register for 5 attendees Price: $5,085.00 $8,475.00 You Save: $3,390.00 (40%)*

Register for 10 attendees Price: $9,322.00 $16,950.00 You Save: $7,628.00 (45%)*

 Register now and save $200. (Early Bird)

Until April 10, Early Bird Price: $1,695.00 From April 11 to May 17, Regular Price: $1,895.00

Sponsorship Program benefits for “New EU Medical Device Regulation | Updated Regulation 2018” seminar

For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel

john.robinson@globalcompliancepanel.com  

support@globalcompliancepanel.com 

Toll free: +1-800-447-9407

Phone: +1-510-584-9661

 Website: http://www.globalcompliancepanel.com

Registration Link - https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901618SEMINAR?SEO

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

Follow us on Twitter: https://twitter.com/GCPanel

Speaker

Salma Michor

PhD, MSc, MBA, CMgr, RAC 

Salma Michor is founder and CEO of Michor Consulting Schweiz GmbH, serving such clients as Johnson & Johnson, Novartis, Shire, Pfizer and Colgate Palmolive. Previously, Michor worked for Chiesi-Torrex, Wyeth Whitehall Export Croma Pharma GmbH. She teaches regulatory affairs and clinical strategies at the University of Krems, Austria, and is an independent expert to the European Commission. She holds a PhD in thermal process engineering and an MSc in food and biotechnology from the University of Applied Life Sciences in Vienna, Austria; an MSc from King's College, University of London in food technology; and an MBA from Open University, and has earned the RAC (EU), CQA and is a Chartered manager.